Pacific Edge Limited has reached its first commercial agreement of scale in Australia with Northern Health, a major provider of healthcare and hospital services to Melbourne's rapidly growing outer northern suburbs. Initially, urologists at Northern Health will use Cxbladder Monitor to help manage patients undergoing surveillance following treatment of their bladder cancer. Cxbladder Monitor will be used to identify those patients who can safely forego or defer a flexible cystoscopy at their next scheduled hospital visit. Once implemented, the service will be extended to use Cxbladder Triage for the evaluation of patients referred to urology for investigation of haematuria (blood in the urine and a key indicator of bladder cancer). Northern Health will coordinate patient sample collection, and shipping to Pacific Edge for analysis at its CLIA approved and IANZ-accredited laboratory in Dunedin, New Zealand.